A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization
PLoS ONE, ISSN: 1932-6203, Vol: 8, Issue: 8, Page: e72268
2013
- 11Citations
- 252Usage
- 38Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes9
- CrossRef7
- Policy Citations2
- Policy Citation2
- Usage252
- Downloads227
- Abstract Views25
- Captures38
- Readers38
- 38
Article Description
Commercialization within the academic setting is associated with many challenges and barriers. Previous studies investigating these challenges/barriers have, in general, broadly focused on multiple disciplines and, oftentimes, several institutions simultaneously. The goal of the study presented here was to analyze a range of barriers that may be broadly associated with commercializing academic-based cancer research. This goal was addressed via a study of the barriers associated with cancer research commercialization at the University of Kentucky (UK). To this end, a research instrument in the form of an electronic survey was developed. General demographic information was collected on study participants and two research questions were addressed: 1) What are the general barriers inhibiting cancer research commercialization at UK? and 2) Would mitigation of the barriers potentially enhance faculty engagement in commercialization activities? Descriptive and statistical analysis of the data reveal that multiple barriers likely inhibit cancer research commercialization at UK with expense, time, infrastructure, and lack of industry partnerships being among the most commonly cited factors. The potential alleviation of these factors in addition to revised University policies/procedures, risk mitigation, more emphasis on commercialization by academia research field, and increased information on how to commercialize significantly correlated with the potential for increased commercialization activity. Furthermore, multivariate logistic regression modeling demonstrated that research commercialization would incrementally increase as barriers to the process are removed and that PhD-holding respondents and respondents in commercialization-supportive research fields would be more likely to commercialize their research upon barrier removal. Overall, as with other disciplines, these data suggest that for innovations derived from academic cancer-research to move more effectively and efficiently into the marketplace, university administrators and external agents, such as policymakers, need to address what are well-documented and defined issues. © 2013 Vanderford et al.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84882665787&origin=inward; http://dx.doi.org/10.1371/journal.pone.0072268; http://www.ncbi.nlm.nih.gov/pubmed/23991077; https://dx.plos.org/10.1371/journal.pone.0072268.g002; http://dx.doi.org/10.1371/journal.pone.0072268.g002; http://dx.plos.org/10.1371/journal.pone.0072268.g001; http://dx.doi.org/10.1371/journal.pone.0072268.g001; https://dx.plos.org/10.1371/journal.pone.0072268; https://uknowledge.uky.edu/markey_facpub/3; https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1002&context=markey_facpub; https://dx.doi.org/10.1371/journal.pone.0072268; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0072268; https://dx.doi.org/10.1371/journal.pone.0072268.g001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0072268.g001; https://dx.doi.org/10.1371/journal.pone.0072268.g002; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0072268.g002; http://www.plosone.org/article/metrics/info:doi/10.1371/journal.pone.0072268; http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0072268&type=printable; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0072268; https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0072268&type=printable; http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0072268; http://dx.plos.org/10.1371/journal.pone.0072268.g002; http://dx.plos.org/10.1371/journal.pone.0072268
Public Library of Science (PLoS)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know